Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The biomaterials market was valued at USD 167.39 Billion in 2025. It is poised to grow at a CAGR of 14.20% during the forecast period of 2026-2035, and reach USD 631.53 Billion by 2035. The market growth is driven by the growing demand for implants and prosthetics, advancements in regenerative medicine, and an increasing aging population, fueling market growth, alongside innovations in biocompatible materials and rising healthcare expenditure worldwide.
Base Year
Historical Period
Forecast Period
In January 2026, Microfluidic biomaterials research advanced as an arXiv study demonstrated scalable DNA hydrogel fabrication with controlled properties for biosensing, drug delivery, and tissue engineering.
In January 2026, Researchers developed programmable DNA-based hydrogels with tunable degradation and controlled antibody release, enabling precise drug delivery and advancing personalized biomaterials-based therapeutic systems.
In May 2025, AstraZeneca announced the acquisition of Belgian biotech EsoBiotec for up to $1 billion to enhance its in vivo cell therapy platform. This move integrates biomaterials-enabled delivery systems with cell therapies, supporting next-generation regenerative medicine, and reinforcing the role of biomaterials in precision oncology and advanced therapeutics.
Compound Annual Growth Rate
14.2%
Value in USD Billion
2026-2035
*this image is indicative*
The biomaterials market is expanding steadily, driven by increasing demand for advanced polymer biomaterial applications in medical devices and implants. Growing use of ceramic biomaterials and collagen-based materials supports orthopedic and cardiovascular treatments. Innovations in degradable biomaterials and tissue engineering scaffolds are enhancing clinical outcomes, while advancements in surface modification are improving implant performance and long-term therapeutic efficiency. The market reached a value of approximately USD 167.39 Billion in 2025.
Growing Focus on Smart Drug Delivery Systems to Propel the Market Demand
Increasing focus on programmable biomaterials is advancing next-generation therapeutics, particularly enhancing hydrogel-based delivery systems. For instance, in January 2026, researchers developed DNA-based hydrogels with tunable degradation and controlled antibody release capabilities. These smart biomaterials allow precise modulation of drug delivery and responsiveness to biological triggers, supporting personalized medicine approaches and enhancing the role of biomaterials in advanced therapeutic systems.
Key trends shaping the market include smart biomaterials, injectable hydrogels, microfluidic fabrication, regenerative medicine demand, and growing interdisciplinary research collaborations globally.
Technological Advancements in Biomaterials Engineering to Support the Market Expansion
Technological convergence between microfluidics and biomaterials engineering is advancing therapeutic innovation, particularly improving biocompatibility across next-generation solutions. For instance, in February 2026, a study titled “Microfluidic Fabrication of DNA Hydrogels with Controlled Swelling and Dissolution Properties,” published on arXiv, introduced a scalable fabrication approach enabling precise control over hydrogel properties, supporting applications in biosensing, drug delivery, and tissue engineering. These advancements support high-precision applications such as biosensing, targeted drug delivery, and tissue engineering, strengthening the role of engineered biomaterials in translational research.
Market Breakup by Product Type
Market Breakup by Application
Market Breakup by Region
Metallic Segment Expected to Lead the Market Segment by Product Type
The market share was led by the metallic segment, which held the largest share of above 40% in the historical period. This dominance is attributed to its extensive use in orthopedic and titanium implant applications, along with dental and cardiovascular devices. Strong durability and cost-effectiveness further supported adoption. Increasing demand for advanced medical implants and continuous material innovation also contributed to sustained global growth.
North America held the largest share of around 38% of the global market in the historical period. This leadership is driven by advanced healthcare infrastructure, high adoption of innovative biomaterials, and growing demand for tissue engineering scaffold solutions. Additionally, rising chronic disease prevalence, increasing surgical procedures, and significant R&D investments further strengthened the region’s overall market dominance.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Noble Biomaterials Inc. is a U.S.-based advanced materials company headquartered in Scranton, Pennsylvania, and founded in 1997. It specializes in antimicrobial and conductive biomaterials used in medical textiles, wound care, and infection control. Its key portfolio includes silver-based technologies like Ionic+® and Circuitex®, widely used in healthcare, military, and performance apparel applications for enhanced protection and biocompatibility.
Zimmer Biomet is a leading U.S. medical device company headquartered in Warsaw, Indiana, established in 1927. It offers a strong biomaterials portfolio focused on orthopedic implants, joint reconstruction, spine systems, and bone graft substitutes. The company is a global leader in regenerative orthopedic solutions, supporting knee, hip, and dental applications with advanced implantable biomaterials and robotic-assisted surgical technologies.
Corbion NV is a Netherlands-based company headquartered in Amsterdam and founded in 1919. It focuses on sustainable biomaterials including lactic acid, polylactic acid (PLA), and biodegradable polymers. Its portfolio supports medical implants, tissue regeneration, drug delivery systems, and orthopedic applications, making it a key player in bio-based and eco-friendly medical material innovations.
Koninklijke DSM N.V. is a Dutch multinational headquartered in Heerlen, Netherlands, founded in 1902. It provides advanced biomaterials for regenerative medicine, biocompatible polymers, and medical-grade materials. Its portfolio supports tissue engineering, implantable devices, and drug delivery systems, with a strong emphasis on sustainable life sciences solutions and innovative biomedical material development globally.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are BASF SE, Covestro AG, Celanese Corporation, Carpenter Technology Corporation, Evonik Industries AG, Victrex plc, Coorstek Inc., and CeramTec GmbH.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share